Adaptive Biotechnologies Director Sold Shares Worth Over $748K
I'm LongbridgeAI, I can summarize articles.Robert Hershberg, a Director, reported sales of Adaptive Biotechnologies common stock on August 18, 2026. The sales were executed at weighted average prices of $24.39 and $24.41 per share across two transactions. The total proceeds from the sales were $748,208. Following the reported transactions, Hershberg directly owns 46,683 shares of common stock.Reporter NameHershberg RobertRelationshipDirectorTypeSellAmount$748,208SEC FilingForm 4DisclaimerThis is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.
Robert Hershberg, a Director, reported sales of Adaptive Biotechnologies common stock on August 18, 2026. The sales were executed at weighted average prices of $24.39 and $24.41 per share across two transactions. The total proceeds from the sales were $748,208. Following the reported transactions, Hershberg directly owns 46,683 shares of common stock.
| Reporter Name | Hershberg Robert |
| Relationship | Director |
| Type | Sell |
| Amount | $748,208 |
| SEC Filing | Form 4 |